Cross Country Healthcare Reports Q4 Loss, Revenue Miss; Shares Drop Sharply
Shares of Cross Country Healthcare Inc (NASDAQ:CCRN) fell sharply in after-hours trading following the release of its fourth-quarter and full-year 2025 financial results. The healthcare staffing and workforce solutions company reported a significant net loss and revenue that fell short of analyst expectations, painting a picture of a business navigating a difficult market and the aftermath of a terminated merger.
Earnings and Revenue Versus Estimates
The company's quarterly performance missed Wall Street's targets on both the top and bottom lines. The reported figures highlight the ongoing pressures in the travel staffing sector.
- Revenue: Cross Country reported Q4 revenue of $236.8 million. This represents a substantial 24% decline compared to the fourth quarter of 2024 and fell short of the analyst consensus estimate of approximately $259.4 million.
- Earnings Per Share (EPS): The company reported a diluted net loss per share of $2.56. On an adjusted basis, which excludes certain one-time items, the loss was $0.06 per share. This adjusted figure missed the analyst estimate for a profit of $0.03 per share.
For the full year 2025, revenue was $1.05 billion, down 22% year-over-year. The net loss for the year was $94.9 million, or $2.93 per diluted share, compared to a loss of $14.6 million in 2024.
Market Reaction and Press Release Highlights
The immediate market reaction was negative, with the stock declining over 12% in after-market trading. This sell-off reflects investor disappointment with the earnings miss and the company's outlook for the current quarter.
The earnings press release detailed several key factors behind the quarterly results:
- Significant Impairment Charges: The quarter was heavily impacted by a non-cash goodwill and trade name impairment charge of $77.9 million. This assessment was triggered by a decline in the company's market capitalization following the termination of its merger agreement with Aya Healthcare. An additional $29.6 million valuation allowance against deferred tax assets further weighed on the net loss.
- Segment Performance: Both of Cross Country's core segments saw revenue declines.
- Nurse and Allied Staffing revenue decreased 24% year-over-year to $194.2 million.
- Physician Staffing revenue decreased 20% to $42.5 million.
- Balance Sheet Strength: Despite the operational challenges, the company emphasized its solid financial position. It ended the year with $108.7 million in cash, no debt, and continued positive cash flow from operations. During the quarter, it also repurchased over 800,000 shares of its common stock.
Forward Outlook and Analyst Comparisons
Management provided guidance for the first quarter of 2026, which suggests the current challenging environment is expected to persist in the near term.
- Q1 2026 Revenue Guidance: The company expects revenue between $235 million and $240 million. At the midpoint, this represents an approximate 19% year-over-year decline and is below the current analyst sales estimate of $261.9 million for the quarter.
- Q1 2026 Adjusted EBITDA Guidance: Forecasted to be between $4.0 million and $5.0 million.
- Q1 2026 Adjusted EPS Guidance: The company anticipates an adjusted loss per share between $0.06 and $0.04.
CEO Kevin Clark acknowledged the "challenging market backdrop" but expressed optimism for a sequential progression throughout 2026, citing the company's focus on its proprietary Intellify® technology platform and a strong balance sheet. The company's stated goal is to exit 2026 at an annual revenue run-rate above $1 billion.
For a detailed look at historical earnings, future estimates, and analyst projections, visit the CCRN earnings page on Chartmill.
Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation to buy or sell any security, or an endorsement of any investment strategy. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.
